|
14 Feb 2010 |
Idera Pharmaceuticals Presents Preclinical Hyperlipidemia Data on a Toll-like Receptor Antagonist at Keystone Symposium
|
|
10 Feb 2010 |
Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
|
|
10 Feb 2010 |
ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK
|
|
10 Feb 2010 |
StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
|
|
10 Feb 2010 |
Mipomersen Phase 3 Study in Patients with Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint
|
|
04 Feb 2010 |
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
|
|
04 Feb 2010 |
AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology
|
|
03 Feb 2010 |
Data on ATL1101 Prostate Tumour Suppression Published in Scientific Journal & Australian Patent Granted
|
|
02 Feb 2010 |
California Stem Cell and ALS Therapy Development Institute Extend Their Collaboration to Advance Potential Stem Cell Assisted Therapy for ALS
|
|
01 Feb 2010 |
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
|
|
29 Jan 2010 |
CellProthera achieves a revolutionary breakthrough in the treatment of myocardial infarction with the support of the Alsace Region and the Alsace BioValley biocluster
|
|
28 Jan 2010 |
First Refractory Angina Patient treated with VEGF-D shortform (EG011) in Phase I/IIa trial
|
|
28 Jan 2010 |
Regulatory Update
|
|
28 Jan 2010 |
Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Intended for Autoimmune Disease Indications
|
|
27 Jan 2010 |
ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
|
|
26 Jan 2010 |
Geron Forms Collaboration to Investigate GRNOPC1 in Alzheimer's Disease Models
|
|
26 Jan 2010 |
Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection
|
|
26 Jan 2010 |
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
|
|
25 Jan 2010 |
Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes
|
|
22 Jan 2010 |
DATA FROM TNFERADE ESOPHAGEAL CANCER STUDY PRESENTED AT 2010 ASCO GASTROINTESTINAL CANCER SYMPOSIUM
|
|
21 Jan 2010 |
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
|
|
19 Jan 2010 |
Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS
|
|
19 Jan 2010 |
Idera Pharmaceuticals Announces Achievement of Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment
|
|
19 Jan 2010 |
GENVEC ENTERS COLLABORATION ON HEARING LOSS TREATMENTS WITH LEADING GLOBAL PHARMACEUTICAL COMPANY
|
|
13 Jan 2010 |
Sirnaomics Licenses Polypeptide Nanoparticle Technology for Its siRNA Therapeutic Product Development
|
